Syndax Pharmaceuticals Inc
SNDX· Nasdaq
SNDXSyndax Pharmaceuticals Inc
Filed Nov 8, 2017 · 10-Q · 39 days after period end · 0001193125-17-336444
| Metric | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|
| Revenue | $305.00K | $305.00K | $305.00K |
| Net Income | -$15.09M | -$14.97M | -$7.73M |
| EPS Diluted | -$0.84 | -$0.84 | -$790.85 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Syndax Pharmaceuticals Inc · CIK 1395937 · Engraved from SEC EDGAR
ended Sep 30, 2017 · filed Nov 8, 2017 · 39 d after period end
